BrainScope announced today the release of a white paper which demonstrates a significant positive impact on the costs to the healthcare system from integrating BrainScope One into the assessment of mild traumatic brain injury / concussion. Escalating awareness of the consequences of traumatic brain injury, even when mild, has resulted in an increasing burden to the healthcare system of $76.5 billion annually. Overall findings of the white paper, authored by a well-respected team comprised of an economist and actuaries, demonstrated that the use of BrainScope One in the Emergency Department and Community settings (including Urgent Care Centers) could result in a significant reduction of costs of up to 32.2%. This is accomplished by a combination of diversion from hospital emergency departments to less expensive care settings, as well as a significant reduction in the number of unnecessary CT scans with the implementation of BrainScope One in the patient care pathway. These results, derived from an economic and actuarial impact model (the BrainScope One Economic Analyzer Model, or “BEAM”), demonstrate the potential savings to healthcare payers and patients that can be realized through the adoption of BrainScope One during the assessment of head-injured patients.
Lead author Judith Bentkover, a Professor of the Practice at Brown University’s School of Public Health and Tufts University’s Economics Department, stated, “As a health economist teaching healthcare policy, I am personally very excited about the potential for BrainScope One to greatly improve the cost-effective diagnosis and treatment of patients with mild head injuries. By offering a safer, effective treatment option that also improves provider efficiency and saves healthcare dollars, BrainScope One is an example of a medical device that is much needed in today’s challenging healthcare environment.”
Co-Author Ian Duncan, a health actuary with over 40 years of experience and an Adjunct Professor of Actuarial Statistics at the University of California, Santa Barbara, stated, “Our economic model shows that the FDA-cleared BrainScope device has the potential to save significant resources and costs for patients with mild Traumatic Brain Injury.”
BEAM was specifically developed to compare costs between patient care pathways, one including BrainScope One and the other without, associated with the initial triage of mild traumatic brain injury / concussion patients for a commercially-insured population using data from an IBM Watson database. The model shows the net economic impact, as well as a more detailed cost savings breakdown for payers and patients, which represent just one piece of the overall benefits to the healthcare system.
The authors also noted that beyond the financial impact, there are multiple additional benefits from BrainScope One that positively impact the collective stakeholders of the healthcare system, including payers, patients, and providers, as follows: “These broader benefits to the healthcare system associated with BrainScope One’s integration include decreased ED overcrowding by diverting patients and reducing ED referrals; reduced radiation exposure by avoiding unnecessary CT Scans; increased care access points by integrating device in various patient care settings including rural settings where CT may not be available; decreased processing time for non-critical patients by lowering the number of touchpoints during triage, thereby freeing capacity for higher acuity patients; early intervention through objective functional injury data; reduced patient wait times, increasing productivity and improving patient satisfaction; and provision of objective data to aid clinicians in making a more informed and confident decisions to hold patients for observation.”